141 related articles for article (PubMed ID: 32908579)
1. Discovery of Prognostic Signature Genes for Overall Survival Prediction in Gastric Cancer.
Meng C; Xia S; He Y; Tang X; Zhang G; Zhou T
Comput Math Methods Med; 2020; 2020():5479279. PubMed ID: 32908579
[TBL] [Abstract][Full Text] [Related]
2. A 5-Gene Prognostic Combination for Predicting Survival of Patients with Gastric Cancer.
Song L; Wang XY; He XF
Med Sci Monit; 2019 Aug; 25():6313-6320. PubMed ID: 31422414
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract][Full Text] [Related]
4. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
5. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
6. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
Front Immunol; 2021; 12():719628. PubMed ID: 34413861
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
9. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
12. A Six-Gene Signature Predicts Clinical Outcome of Gastric Adenocarcinoma.
Li Y; Yu Q; Zhu R; Wang Y; Li J; Wang Q; Guo W; Fu S; Zhu L
Comb Chem High Throughput Screen; 2018; 21(6):444-452. PubMed ID: 29848271
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
14. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
15. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
Zhao E; Zhou C; Chen S
Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
17. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
[TBL] [Abstract][Full Text] [Related]
18. Predictive and Prognostic Value of an MicroRNA Signature for Gastric Carcinoma Undergoing Adjuvant Chemotherapy.
Cheng X; Wei H; Zhang S; Zhang F
DNA Cell Biol; 2021 Nov; 40(11):1428-1444. PubMed ID: 34767733
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel gene pairs signature in the prognosis of gastric cancer.
Peng PL; Zhou XY; Yi GD; Chen PF; Wang F; Dong WG
Cancer Med; 2018 Feb; 7(2):344-350. PubMed ID: 29282891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]